UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 8-K 

 

CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 30, 2018

 

Milestone Scientific Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

Delaware
(State or other jurisdiction
of incorporation)

 

001-14053
(Commission
File Number)

 

13-3545623
(IRS Employer
Identification No.)

 

 

 

220 South Orange Avenue,

Livingston Corporate Park 
Livingston, New Jersey
(Address of principal executive offices)

 

070340
(Zip Code)

 

Registrant’s telephone number, including area code (973) 535-2717

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 


 

 

 

 

 

Item 5.07 — Submission of Matters to a Vote of Security Holders

 

The 2018 Annual Meeting of Stockholders (the “Annual Meeting”) of Milestone Scientific Inc. (the “Company”) was held on May 30, 2018. At the Annual Meeting, the Company’s stockholders:

 

 

Elected six incumbent directors to serve until the next annual meeting of the Company’s stockholders or until their respective successors have been duly elected and qualified; and

 

 

Approved, on an advisory basis, the appointment of Friedman LLP as the Company’s independent auditors for the fiscal year ending December 31, 2018.

 

The number of votes cast for, against or withheld and the number of abstentions and broker non-votes with respect to each Proposal is set forth below.

 

Proposal 1

 

Shares For

 

Shares Withheld

 

Broker Non-Votes

Leslie Bernhard

11,720,914   

164,412

16,052,871      

Leonard Osser

11,723,966   

161,360

16.052,871      

Leonard M. Schiller

11,723,966   

161,360

16,052,871      

Gian Domenico Trombetta

11,723,971   

161,355

16,052,871      

Edward Zelnick, M.D.

11,720,994   

164,332

16,052,871      

Michael McGeehan

11,721,655   

163,671

16,052,871      

 

Proposal 2

 

Shares For

Shares Against

Shares

Abstaining

Broker

Non-Votes

Advisory approval of Friedman LLP as the Company’s independent auditors for the 2018 fiscal year

27,722,667   

215,530   

-0-   

-0-   

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

Milestone Scientific Inc.
 

 

Dated: May 31, 2018

By:  

/s/ Joseph D’Agostino 

 

 

 

Joseph D’Agostino 

 

 

 

Chief Financial Officer